X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2021/07/28/2270259/0/en/Alkahest-Strengthens-Management-Team-with-Addition-of-C%C3%A9sar-Cerezo-as-Chief-Medical-Officer.html
http://www.globenewswire.com/news-release/2021/03/08/2188969/0/en/Alkahest-to-Present-Positive-Data-from-Completed-Phase-2-Clinical-Trial-at-the-15th-International-Conference-on-Alzheimer-s-and-Parkinson-s-Disease.html
https://www.globenewswire.com/news-release/2021/01/28/2165766/0/en/Alkahest-Announces-Peer-Reviewed-Publication-Demonstrating-Safety-and-Tolerability-of-GRF6019-in-Patients-with-Mild-to-Moderate-Alzheimer-s-Disease.html
https://www.biospace.com/article/releases/grifols-to-acquire-alkahest-to-enhance-discovery-research-and-development-to-identify-innovative-therapies-for-age-related-diseases-based-upon-an-understanding-of-the-human-plasma-proteome/?s=79
https://www.prnewswire.com/news-releases/grifols-to-acquire-alkahest-to-enhance-discovery-research-and-development-to-identify-innovative-therapies-for-age-related-diseases-based-upon-an-understanding-of-the-human-plasma-proteome-301124953.html
https://www.globenewswire.com/news-release/2020/07/09/2059862/0/en/Alkahest-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2020/06/01/2041375/0/en/Alkahest-Announces-Initiation-of-Phase-2-Study-AKST1210-201-Exploring-Treatment-of-Cognitive-Impairment-in-End-Stage-Renal-Disease-Patients.html
https://www.globenewswire.com/news-release/2020/02/04/1979397/0/en/Alkahest-Initiates-a-Phase-2-Clinical-Trial-of-AKST4290-in-Parkinson-s-Disease-with-Funding-from-The-Michael-J-Fox-Foundation.html
https://www.biospace.com/article/releases/alkahest-initiates-phase-2-clinical-and-mechanistic-trial-of-akst4290-on-choroidal-blood-flow-in-age-related-macular-degeneration/?s=62
Market Place
Share 
